Abstract
279 (PB-095) Poster - Reassessment of HER2 Status in Invasive Micropapillary Carcinoma of the Breast - Recommendations for Improvement of 2023 ASCO/CAP Guideline on HER2 Testing
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
